Cardiology trial failures: two drugs no better than placebo, hypotheses questioned

Full data from two major cardiology trials presented Saturday showed the investigational drugs performed no better than placebo, dashing high expectations. The failures raise questions about trial design and the underlying biological hypotheses for heart disease, potentially resetting the research agenda in the field.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works